Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate
Alexiane Pradelle, Sabine Mainbourg, Steeve Provencher, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116055-116055
Open Access | Times Cited: 24

Showing 24 citing articles:

Demographic Variation In US Outpatient Hydroxychloroquine And Ivermectin Use During The COVID-19 Pandemic
Michelle S. Rockwell, Sitaram Vangala, Michael G.‏ Hadfield, et al.
Health Affairs (2025)
Closed Access
Challenges and Reflections on Pandemic Disinformation: The Case of Hydroxychloroquine and the Implications for Global Public Health
Heslley Machado Silva
Value in Health Regional Issues (2024) Vol. 43, pp. 101005-101005
Closed Access | Times Cited: 3
The resilience of public science and effectiveness of policy handling of technical advice
C. W. M. Whitty
Future Healthcare Journal (2024) Vol. 11, Iss. 1, pp. 100024-100024
Open Access | Times Cited: 1
Fraud in Medical Publications
Consolato Gianluca Nato, Federico Bilotta
Anesthesiology Clinics (2024) Vol. 42, Iss. 4, pp. 607-616
Closed Access | Times Cited: 1
The shifting impact and response to COVID-19 in Florida
Scott A. Rivkees
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic
Jean‐Luc Cracowski, Mathiéu Molimard, Vincent Richard, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 8, pp. 959-967
Closed Access | Times Cited: 1
Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: the devil is in the details.
Charlotte Beaudart, Jonathan Douxfils, Flora T. Musuamba, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pooled evidence precision of clinical trials on hydroxychloroquine for Covid-19 treatment was stabilized eight months after the outbreak
Tatiane Bomfim Ribeiro, Paula Camila Ramírez, Luís Ricardo Santos de Melo, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Clinical study types and guidance for their correct post-pandemic interpretation
Manuel Martı́nez-Sellés, Luís Prieto
Revista Española de Quimioterapia (2024) Vol. 37, Iss. 3, pp. 203-208
Open Access
Hydroxychloroquine as a potential therapy for ANCA-associated vasculitis
Sahil Jain, Shirish Sangle, Sangmi Kim, et al.
Vessel Plus (2024)
Open Access
Premature Closure of Scientific Thinking: Deaths Due to Chloroquine and Hydroxychloroquine Used for COVID-19 Infection
Peter Manu
American Journal of Therapeutics (2024) Vol. 31, Iss. 2, pp. e186-e187
Closed Access

J Barberán López, F. Lerma, Víctor Asensi, et al.
Revista Española de Quimioterapia (2024) Vol. 37, Iss. 3
Open Access
NOTÍCIA FALSA SOBRE COVID-19: RELAÇÕES DIALÓGICAS ENTRE TÉCNICAS DE PERSUASÃO E EFEITOS DE LEGITIMIDADE E CREDIBILIDADE
Guilherme da Silva Lima, Victoria Silva e Oliveira
Linguagem em (Dis)curso (2024) Vol. 24
Open Access
Entre o passado e o presente: a presença militar no âmbito da gestão de crises sanitárias no Brasil
Kleiton Wagner Alves da Silva Nogueira
Germinal Marxismo e Educação em Debate (2024) Vol. 16, Iss. 1, pp. 364-387
Open Access
Reckoning with COVID-19 denial: Brazil's exemplary model for global response
Heslley Machado Silva
World Journal of Methodology (2024) Vol. 14, Iss. 3
Open Access
#EpiTwitter: Public Health Messaging During the COVID-19 Pandemic (Preprint)
Ashwin Rao, Nazanin Sabri, Siyi Guo, et al.
(2024)
Closed Access
What are the clinical and research lessons learned from immunomodulators and other therapies during the COVID-19 pandemic?
Daniel A. Sweeney, Pedro Póvoa
Current Opinion in Critical Care (2024) Vol. 30, Iss. 5, pp. 420-426
Closed Access
Vioces Against Violence: Empowering Students To Address Domestic Terrorism Through Digital Activism
Tracy Khan, Rebeca Perren, Nancy Quintanilla
Marketing Education Review (2024) Vol. 34, Iss. 4, pp. 324-346
Closed Access
Exploring the Role of News Outlets in the Rise of a Conspiracy Theory: Hydroxychloroquine in the Early Days of COVID-19
Robert E. Dickinson, Dominique Makowski, Harm van Marwijk, et al.
COVID (2024) Vol. 4, Iss. 12, pp. 1873-1896
Open Access
Public Health Messaging on Twitter During the COVID-19 Pandemic: An Observational Study (Preprint)
Ashwin Rao, Nazanin Sabri, Siyi Guo, et al.
Journal of Medical Internet Research (2024) Vol. 27, pp. e63910-e63910
Open Access
Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patients
Sabine Hazan, A. Vidal, Nicolas Hulscher, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access
What the SARS-CoV-2 Pandemic Has Taught Us About Immunosuppression, Vaccinations, and Immune Dysregulation: The Rheumatology Experience
Yike Jiang, Rebecca E. Sadun
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 4, pp. 221-232
Open Access
El enigma del coronavirus – Nuevos conocimientos sobre el COVID prolongado – Vacunas
José Pacheco Romero
Revista Peruana de Ginecología y Obstetricia (2024) Vol. 70, Iss. 1
Open Access
AGNOTOLOGIA, DESINFORMAÇÃO REMUNERADA E NEGACIONISMO CIENTÍFICO COMO IDEOLOGIA NA CULTURA ALGORÍTMICA
Rafael Brito de Moura, Cidoval Morais de Sousa
Revista Contemporânea (2024) Vol. 4, Iss. 10, pp. e6238-e6238
Closed Access
Page 1

Scroll to top